What is NCEL's current stock price?

NCEL (NewcelX Ltd.) is currently trading at $3.16 with a market cap of $1.4M.

What sector is NewcelX Ltd. in?

NewcelX Ltd. (NCEL) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

NCEL NewcelX Ltd.

Healthcare

$3.16-0.63%ClosedMarket Cap: $1.4M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.44

P/S

0.00

EV/EBITDA

0.43

DCF Value

$10.10

FCF Yield

-338.6%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-101.0%

ROA

-49.9%

ROIC

-142.4%

Financials

View All

Period	Revenue	Net Income	EPS
Q2 null	$0.00	$-2.2M	$—
Q4 null	$0.00	$55.0K	$—
FY null	$0.00	$-2.0M	$—
Q2 null	$0.00	$-2.0M	$—

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All

Samuel Olivierdirector

BuyWed Apr 29

Samuel Olivierdirector

BuyWed Apr 29

Revel Micheldirector, 10 percent owner, officer: CSO and Director

BuyWed Apr 29

Revel Micheldirector, 10 percent owner, officer: CSO and Director

BuyWed Apr 29

Zwyer Alexanderdirector

SellWed Mar 18

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

1.00

NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.

Peers

PRE